MOLINA HEALTHCARE INC
MOHNYSETrading Snapshot
- Day Range
- $193.01 – $198.25
- 52-Week Range
- $121.06 – $244.89
- Volume
- $3.00B
- Avg Volume
- $2.24B
- Shares Outstanding
- 52.2M
- Next Earnings
- Sep 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $45.43B
- Last Q Revenue
- $10.87B
- P/E Ratio
- —
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-0.21
- Dividend Yield
- —
Why Investors Own MOH
- ✓High-growth profile — revenue up +56.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 47% gross margin and 6% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About MOLINA HEALTHCARE INC
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?
UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.
Molina Healthcare: Management Has Made The Difficult Decision For Long-Term Benefit
Molina Healthcare (MOH) is upgraded to Buy with ~20% upside, driven by strategic ACA exit and Medicaid strength.
Oakmark Global All Cap Strategy Q2 2026 Portfolio Performance
The Oakmark Global All Cap Strategy returned 8.05% in Q2 2026, trailing its benchmark due to headwinds in software and media. Read the full analysis for more.
Oscar Health Flashes Buy Signal As Medicaid Weighs On Centene
S&P 500 health insurer Centene blew away Q2 earnings forecasts amid lower-than-expected Affordable Care Act Marketplace benefit costs. Oscar Health, a pure play on the ACA, flashed an early entry buy signal amid Centene's good news and a big price target hike.
S&P 500 Stock Centene Dives On Medicaid Outlook
S&P 500 health insurer Centene blew away Q2 earnings forecasts amid lower-than-expected Affordable Care Act Marketplace benefit costs. CNC stock initially moved higher, but shares reversed sharply lower as the company discussed its outlook, including slightly higher Medicaid attrition and a more costly covered population in the second half of 2026. Centene posted Q2 earnings of $2.51 a share, crushing forecasts of $1.09 by $1.42 a share.
Centene Finds Profit Growth Even as Medicaid Membership Softens
Centene beat Q2 earnings and revenue estimates, raised its 2026 outlook, improved medical cost trends, and reported lower Medicaid membership.